Shan; Ning
Patent Applications and Registrations
Patent applications and USPTO patent grants for Shan; Ning.The latest application filed is for "treatment of neurological disease".
Company Profile
8.25.29
- Shan; Ning - Chandler AZ
- Shan; Ning - Sunnyvale CA
- Shan; Ning - Tampa FL
Patent Activity
| Patent | Date |
|---|---|
| Treatment Of Neurological Disease App 20220265635 - Mead; Richard James ; et al. | 2022-08-25 |
| Securing Workload And Application Access From Unauthorized Entities App 20210392135 - Rao; Supreeth ; et al. | 2021-12-16 |
| Treatment Of Neurological Disease App 20210353613 - Shan; Ning ; et al. | 2021-11-18 |
| Crystalline Form Of S-apomorphine App 20210214310 - SHAN; Ning | 2021-07-15 |
| Sublingual opioid formulations containing naloxone Grant 10,874,658 - Shan , et al. December 29, 2 | 2020-12-29 |
| Crystalline forms Grant 10,526,358 - Hanna , et al. J | 2020-01-07 |
| Crystalline forms Grant 10,519,176 - Hanna , et al. Dec | 2019-12-31 |
| Sublingual Opioid Formulations Containing Naloxone App 20190209540 - Shan; Ning ; et al. | 2019-07-11 |
| Crystallization method and bioavailability Grant 10,323,052 - Hanna , et al. | 2019-06-18 |
| Novel Crystalline Forms App 20190144474 - HANNA; Mazen ; et al. | 2019-05-16 |
| Sublingual opioid formulations containing naloxone Grant 10,265,309 - Shan , et al. | 2019-04-23 |
| Novel Crystalline Forms App 20190002483 - HANNA; Mazen ; et al. | 2019-01-03 |
| Crystallization Method And Bioavailability App 20180333425 - HANNA; Mazen ; et al. | 2018-11-22 |
| Crystallization method and bioavailability Grant 10,093,691 - Hanna , et al. October 9, 2 | 2018-10-09 |
| Sublingual Fentanyl Formulations Containing A Permeation Enhancer App 20170340557 - Shan; Ning ; et al. | 2017-11-30 |
| Sublingual Opioid Formulations Containing Naloxone App 20170340620 - Shan; Ning ; et al. | 2017-11-30 |
| Oral forms of a phosphonic acid derivative Grant 9,682,091 - Hanna , et al. June 20, 2 | 2017-06-20 |
| Novel Crystalline Forms App 20170022225 - HANNA; Mazen ; et al. | 2017-01-26 |
| Crystallization Method And Bioavailability App 20170022227 - HANNA; Mazen ; et al. | 2017-01-26 |
| Crystallization Method And Bioavailability App 20170022226 - HANNA; Mazen ; et al. | 2017-01-26 |
| Sublingual Naloxone Spray App 20160199294 - Amancha; Kiran ; et al. | 2016-07-14 |
| Crystalline forms Grant 9,340,565 - Hanna , et al. May 17, 2 | 2016-05-17 |
| Crystallization method and bioavailability Grant 9,334,296 - Hanna , et al. May 10, 2 | 2016-05-10 |
| Crystallization Method And Bioavailability App 20160016982 - HANNA; Mazen ; et al. | 2016-01-21 |
| Novel Oral Forms Of A Phosphonic Acid Derivative App 20150306116 - HANNA; Mazen ; et al. | 2015-10-29 |
| Crystallization method and bioavailability Grant 9,169,279 - Hanna , et al. October 27, 2 | 2015-10-27 |
| Crystalline molecular comlpexes of tadalafil Grant 9,040,535 - Hanna , et al. May 26, 2 | 2015-05-26 |
| Oral forms of a phosphonic acid derivative Grant 8,980,868 - Hanna , et al. March 17, 2 | 2015-03-17 |
| Crystallization method and bioavailability Grant 8,933,057 - Hanna , et al. January 13, 2 | 2015-01-13 |
| Crystallization Method And Bioavailability App 20140107076 - HANNA; Mazen ; et al. | 2014-04-17 |
| Crystalization Of Pharmaceutical Compounds App 20140100233 - HANNA; Mazen ; et al. | 2014-04-10 |
| Crystallization Method And Bioavailability App 20140057875 - HANNA; Mazen ; et al. | 2014-02-27 |
| Novel Crystalline Forms App 20130316982 - Hanna; Mazen ; et al. | 2013-11-28 |
| Crystalline molecular complex of tadalafil and methylparaben Grant 8,586,587 - Hanna , et al. November 19, 2 | 2013-11-19 |
| Crystalline forms of lamotrigine Grant 8,486,927 - Hanna , et al. July 16, 2 | 2013-07-16 |
| Crystallization method and bioavailability Grant 8,399,023 - Hanna , et al. March 19, 2 | 2013-03-19 |
| In vivo studies of crystalline forms of meloxicam Grant 8,389,512 - Hanna , et al. March 5, 2 | 2013-03-05 |
| Crystallization Method And Bioavailability App 20130035315 - HANNA; Mazen ; et al. | 2013-02-07 |
| Novel Oral Forms Of A Phosphonic Acid Derivative App 20120190647 - Hanna; Mazen ; et al. | 2012-07-26 |
| In Vivo Studies of Crystalline Forms of Meloxicam App 20120149692 - Hanna; Mazen ; et al. | 2012-06-14 |
| In vivo studies of crystalline forms of meloxicam Grant 8,124,603 - Hanna , et al. February 28, 2 | 2012-02-28 |
| Crystalization Of Pharmaceutical Compounds App 20120046297 - Hanna; Mazen ; et al. | 2012-02-23 |
| Crystallization Method And Bioavailability App 20110028435 - HANNA; Mazen ; et al. | 2011-02-03 |
| In vivo studies of crystalline forms of meloxicam App 20090203680 - Hanna; Mazen ; et al. | 2009-08-13 |
| Crystalline Forms of lamotrigine App 20090176787 - Hanna; Mazen ; et al. | 2009-07-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 